Immediate Impact
50 standout
Citing Papers
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
2025 Standout
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Works of Laura Seynaeve being referenced
A phase I clinical trial on intratumoral and intracavitary administration of ipilimumab and nivolumab in patients with recurrent glioblastoma.
2020
Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Laura Seynaeve | 51 | 47 | 59 | 92 | 57 | 18 | 298 | |
| Alexander Khorovodov | 9 | 18 | 38 | 24 | 8 | 18 | 288 | |
| Anne Hayman | 21 | 65 | 37 | 38 | 5 | 17 | 263 | |
| Alexander Dubrovsky | 6 | 14 | 47 | 43 | 6 | 17 | 276 | |
| Rosa Morabito | 7 | 39 | 71 | 31 | 9 | 36 | 298 | |
| Xiaofeng Huang | 18 | 13 | 98 | 52 | 9 | 32 | 296 | |
| Yuya Fujita | 8 | 11 | 16 | 105 | 29 | 31 | 278 | |
| Ilana Agranovich | 7 | 15 | 41 | 19 | 9 | 22 | 301 | |
| Takamasa Yokoi | 21 | 29 | 88 | 75 | 7 | 23 | 283 | |
| Christian E. Keller | 21 | 12 | 120 | 73 | 6 | 10 | 333 | |
| Özlem Önerci Çelebi | 11 | 13 | 65 | 48 | 6 | 27 | 301 |
All Works
Login with ORCID to disown or claim papers
Loading papers...